LARGE VOLUME PARENTERAL MARKET ANALYSIS

Large Volume Parenteral Market by Treatment Type (Fluid Balance Injections, Therapeutic Injections, and Nutritious Injections), by End User (Hospitals, Ambulatory centers, Clinics, and Others) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI1323
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Key players operating in large volume parenteral market include Baxter International Inc., Teva Pharmaceutical Industries Limited, Kelun Pharmaceutical Inc., BAG Healthcare GmbH, Hospira, Inc., Patheon Inc., Otsuka Pharmaceutical, Wockhardt Ltd., Southwest Pharmaceutical Co. Ltd., and Cook Pharmica LLC.

In January 2018, Baxter International Inc. announced a distribution agreement for the U.S. launch of the Arisure Closed System Transfer device, which has several component to prevent contaminants from entering the intravenous medication delivery system. This avoids the entry of hazardous substances while administration of therapy. Baxter International Inc. also completed the acquisition of the Claris Injectable Limited in July 2017, which is expected to improve Baxter’s presence in generic injectable market.